HBOT Conversations:
Laurie Anderson (Part 1)
Healing COVID with HBOT
Through her own journey navigating chronic illness, Dr. Laurie has explored and embraced many forms of alternative and non-traditional medicine to support her body for healing. She has gravitated towards practitioners and modalities that treat the whole patient, with the mantra that tending to mind, body and spirit is the true key to lasting health. Over the years, Dr. Laurie has discovered that this often leads to a ‘less is more’ approach. She discovered HBOT when she was struggling to heal from COVID, and now tells anyone who will listen about the power of oxygen and pressure.
Watch the Podcast
We are thrilled to have Dr. Laurie Anderson join us at the HBOT News Network. Dr. Laurie used Hyperbaric Oxygen Therapy to heal from a very serious COVID illness.
Dr. Laurie explains her background to the audience and that she received treatment in Raleigh, NC at the Extivita clinic. Her background is important and intriguing. Dr. Laurie is a Pharmacist by training, a PharmD. While she has done some clinical work in the past, her passion lies in the safety of clinical studies. She focuses on early phase clinical study work, designing risk mitigation strategies for first time in human studies. Dr. Laurie explained that in her line of work she looks at the risk profile of the assets coming out, the design risk mitigation strategies, and then follows them in the clinic to track them to help ensure that they know what’s safe and what isn’t. Essentially, she is part of the team that helps determine if certain drugs are safe and effective.
di Girolamo explains that when he first started looking at hyperbarics, he was personally trying to understand if it was indeed safe and effective. He found that it was, and was blown away that everyone wasn’t using it. This opened the door to Dr. Laurie telling her story of COVID healing with HBOT, and what led her to Extivita.
Dr. Laurie explains that she has a history of lyme diesease, and worked really hard not to get COVID in fear that she would struggle with complete healing. She had been vaccinated and boostered, and when she did get COVID she became very ill. In addition to losing her sense of smell and taste, she had a relentless cough, really awful fatigue, and some shortness of breath that that just wasn’t improving. She ended up on medical leave because she could not work, and when she started to reach the end of the medical leave she still was not improving. Dr. Laurie talked to the naturopath who had been following her for many years, and her naturopath suggested NAD infusions. Dr. Laurie had never heard of NAD infusions before, so she started to read about them and who does them locally in the Raleigh, NC area. That’s when Dr. Laurie was introduced to the Extivita clinic.
Dr. Laurie came to Extivita to start NAD infusions, but was also encouraged to try Hyperbaric Oxygen Therapy to heal from COVID. The clinic explained that they are seeing really great success using hyperbarics for COVID long-hauler patients. Dr. Laurie was hesitant due to her claustrophobia, but in the end she decided it was worth a try. She educated herself on HBOT, and found that there wasn’t a reason why she shouldn’t do it. She was desperate to heal from the COVID infection. So, she committed to 20 dives, 4 days a week and had phenomenal results; claiming significant improvement after only ten dives.
“I got to say, I was kind of blown away because I had been battling with no improvement for long enough to be concerned, and I came in and I think it was about maybe five or six dives in, and my taste and smell started returning. It was completely gone. And I started to see a change probably in maybe eight, nine or ten, that my cough started going away. I would say by 12 or 13 dives, I felt healed, I felt recovered and even better than I felt going in [the way I felt before getting COVID].”
Dr. Laurie exclaimed that she noticed a positive difference in her energy and sleep almost immediately. She was more restful, and she said she pays close attention to those things because her history with chronic illness.
“I just could tell a difference. And in my energy, mainly. My energy level and my sleep really shifted, which was a real gift.”
Dr. Laurie even shared her story in an Extivita testimonal, hopeful that others can also discover the powerful combination of oxygen and pressure to heal from COVID.
Stay tuned next week for Part 2 of Dr. Laurie’s podcast. We will talk with her about some other benefits of HBOT, and we’ll pick her brain on clinical trials involving hyperbaric oxygen therapy.
Guests
Dr. Laurie Anderson, Pharm.D.
Through her own journey navigating chronic illness, Dr. Laurie has explored and embraced many forms of alternative and non-traditional medicine to support her body for healing. She has gravitated towards practitioners and modalities that treat the whole patient, with the mantra that tending to mind, body and spirit is the true key to lasting health. Over the years, Dr. Laurie has discovered that this often leads to a ‘less is more’ approach.
When not working, Dr. Laurie is an avid gardener, ballroom dancer and traveler with her husband. Remaining curious and finding joy in every day are her super powers.
Subscribe Now, It’s Free!
Recent HBOT News
Can a pin-tract infection cause an acute generalized soft tissue infection and a compartment syndrome?
Abstract: A patient who developed soft tissue infection and osteomyelitis secondary to pin tract infection after skeletal traction was evaluated. Tibial traction was performed on a patient who had exposed to a femoral pertrochanteric fracture after falling from a tree...
Clinical Trial – Hyperbaric Oxygen in Lower Leg Trauma
Study hypothesis :Hyperbaric Oxygen may prevent complications and improve outcomes in severe
lower limb trauma. We propose to investigate this hypothesis by conducting an International
multi centre randomised control trial of standard trauma/orthopaedic care with or without a
concurrent course of hyperbaric oxygen treatments.
Clinical Trial – Can Erythropoietin Protect the Cerebral Blood Flow and Oxygenation During Simulated Dive?
During facial cooling and especially during breath hold, can mammals – and also humans –
elicit a so called dive reflex, causing bradycardia, peripheral vasoconstriction and
centralization of blood flow to brain, lungs and heart but the reflex is suppressed by
physical activity. The dive reflex can be elicited by breath hold alone and will be more
pronounced during simultaneously facial cooling, but not by stimulation of other skin
receptors.
The dive reflex has an oxygen conserving effect, because of intense vasoconstriction in both
viscera and muscles, and simultaneously with reduction in cardiac output (CO). Therefore
plasma lactate will rise, to compensate for the lesser regional blood flow. If one
hyperventilates with 100 % oxygen, then the reflex can still be elicited, but it is more
pronounced during asphyxia. Experienced sports divers, who has been diving for more than 7-10
years have reduced post apnea acidosis and oxidational stress, but probably also less
sensitivity for progressive hypoxia and hypercapnia, because these individuals have a more
pronounced dive reflex.
Transcranial Doppler ultrasonography (TCD) gives a reproducibly value for brain perfusion by
continuously non-invasive real-time sampling. A single piezo-electrical transducer sends and
collects ultrasound through the temporal region of the scull, where it is the thinnest.
Hereby can the blood flow of arteria cerebri anterior, media (MCA) and posterior and
basilaris be estimated.
With TCD it can be shown that the cerebral blood flow rises in MCA in healthy subjects during
facial cooling, with normal ventilation, when resting in a supine position without affecting
the systemic blood pressure. Single Photon Emission Computerized Tomography (SPECT)-scanning
during normo-baric and hyperbaric pressure of professional divers breathing 100 % oxygen has
shown to reduce the cerebral blood flow in several regions of the brain.
But it is yet unknown how brain blood flow and metabolism are affected by an "face immersion
dive" and simultaneously prolonged physical activity, and hence a rise in lactate under
hyperbaric pressure (3 meters), breathing atmospheric air, similar to the circumstances for
trained scuba divers work.
Presumably it will cause a fall in brain blood flow and in time cognitive deficits.
Erythropoietin (rhEPO) is a well known drug, used as doping in sports for about 15 years. So
far the only known enhancement in athletic achievement by rhEPO is caused by peripheral
improvements and especially blood capability to transport oxygen to the working muscles; this
has been documented by a rise in haematocrit. rhEPO has also a neuroprotective effect on
neurons in patients with neuron damage caused by cerebral hypoxic ischeamia.
rhEPO work also on a series of cerebral mechanisms, including enhanced motor and spatial
learning and more. Enhanced motor learning may improve the professional divers choices during
work and may be also physical performance and mechanical efficiency. Intravenous injection of
rhEPO will increase rhEPO in cerebrospinal fluids, since rhEPO is capable of crossing blood
brain. All together this may indicate that rhEPO, not only works on physical performance, but
also has effects on the brain. rhEPO has also an effect on the condition of cancer and
dialysis patients, not only explained by merely increased hematocrit.
This project will add new knowledge in the understanding of the mechanisms of clinical use of
rhEPO.
The purpose of this study is to investigate, how brain blood flow and metabolism are affected
by face immersion dive and simultaneously breath hold during normo-baric and hyperbaric
pressure (3 m depth) when breathing atmospheric air in trained sports divers. IL-6, HSP-72,
lactate, ammonium and body-temperature will be measured. Brain and muscle oxygenation will be
measured by near-infrared spectroscopi (NIRS). Furthermore we will investigate whether a
small dose of rhEPO affects mentioned parameters during simulated dive in pressure chamber
with facial cooling.
Hypothesis Brain blood flow in trained divers will be diminished during prolonged physical
activity during simultaneously face immersion dive and breath hold under hyperbaric pressure.
There will be a release of IL-6 and HSP-72. Pretreatment with a small amount of rhEPO before
prolonged physical activity during simulated dive has a protective effect on brain blood flow
and oxygenation.